BSEDenis Chem Lab LtdHighNeutral
Announced Sat, 30 May · 14:34 IST

the Board of Directors of the Company, in their meeting held today i.e. on 30th May, 2026, interalia, has: 1. Approved the Standalone Audited Financial Statements of the Company for Quarter ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹73.00
prior close
₹73.45
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0-0.7-1.0-2.3-4.2-3.6-1.2-2.4-1.8+2.7+1.4
Up moveDown movePending
AI summary

Denis Chem Lab Ltd's Board approved the standalone audited financial results for FY26 ending 31st March 2026. Revenue from operations grew 4.86% to Rs. 18,172 lakh from Rs. 17,330 lakh, while profit after tax increased 4.13% to Rs. 840.93 lakh from Rs. 807.58 lakh. EPS improved to Rs. 6.06 per share from Rs. 5.82. The Board recommended a final dividend of Rs. 2.50 per equity share (25% on face value of Rs. 10), subject to shareholder approval at AGM. New secretarial auditors (Kashyap R. Mehta & Partners) were appointed to fill a casual vacancy caused by the resignation of Nishant Pandya & Associates. Cost auditors (Kiran J. Mehta & Co.) were appointed for FY27. The statutory auditors issued an unmodified opinion, and the company confirmed it is not a large corporate entity.

Likely market impact

The company delivered steady performance with low single-digit growth in revenue and profits. The unchanged dividend signals confidence in financial stability. No audit qualifications reduce investor risk concerns. Fresh appointment of secretarial auditors due to resignation warrants monitoring.